EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY-NC 4.0

The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia

Jeffrey W Taub iD, Steven A Buck, Ana C Xavier iD, Holly Edwards, Larry H Matherly, Yubin Ge

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.31247 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Jeffrey W Taub und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Vinca Alkaloids, Vinca. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ring Screw Textron Endowed Chair, Children's Hospital of Michigan Foundation, Litvak Foundation/Elana Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An attractive flower from the island of Madagascar has in part saved the lives of thousands of children with acute lymphoblastic leukemia (ALL). Random mutations and alterations to the genome led to the evolution of genes encoding enzymes, which would provide the periwinkle flower an arsenal of secondary metabolites to survive within the Madagascar ecosystem. Of the over 200 alkaloid compounds synthesized by the periwinkle, vincristine and vinblastine are the two most well‐known being used for chemotherapy treatments, including for children with ALL. The complexities of the multi‐step biosynthesis of vincristine and vinblastine, which has taken years to decode, highlight the importance of protecting the vast biodiversity on earth as other natural products that can save lives await to be discovered. This review addresses the discovery of vincristine and vinblastine, as well as the history of their existence, in nature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, PhytogenicPrecursor Cell Lymphoblastic Leukemia-LymphomaVinca AlkaloidsVincaChildHumansHistory, 20th CenturyHistory, 21st CenturyVinblastineVincristine

Stichwörter der Autor:innen

acute lymphoblastic leukemiavinblastinevincristine

Substanzen

Antineoplastic Agents, PhytogenicVinblastineVinca AlkaloidsVincristine

Autor:innen und Institutionen

  • Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, USA.
  • Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Division of Hematology/Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA.

ORCID-Profile: Jeffrey W Taub, Ana C Xavier

Förderung

  • Ring Screw Textron Endowed Chair
  • Children's Hospital of Michigan Foundation
  • Litvak Foundation/Elana Fund

Zitieren

APA

Taub, J. W., Buck, S. A., Xavier, A. C., Edwards, H., Matherly, L. H., & Ge, Y. (2024). The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31247

Vancouver

Taub JW, Buck SA, Xavier AC, Edwards H, Matherly LH, Ge Y. The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31247

BibTeX
@article{Taub2024,
  author = {Taub, Jeffrey W and Buck, Steven A and Xavier, Ana C and Edwards, Holly and Matherly, Larry H and Ge, Yubin},
  title = {The evolution and history of Vinca alkaloids: From the Big Bang to the treatment of pediatric acute leukemia},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.31247}
}
Kostenlos starten →